also showed that CD38 knockout CAR-NK cells which were transduced with dual targeting anti-BCMA CAR and CD16 possessed enhanced cytotoxicity and prolonged persistence against multiple myeloma cells (20). The gene discussed is CD38; the disease is plasma cell myeloma.